Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with diverse clinical presentation and outcome. Bio-clinical prognostic models including oncogene expression and cell-of-origin phenotyping has been developed, however, approximately 30% of all patients still die from their disease, il...

Descripción completa

Detalles Bibliográficos
Autores principales: Jespersen, Ditte Starberg, Schönherz, Anna A., Due, Hanne, Bøgsted, Martin, Sondergaard, Teis Esben, Dybkær, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344585/
https://www.ncbi.nlm.nih.gov/pubmed/30674940
http://dx.doi.org/10.1038/s41598-018-36680-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344585/
https://www.ncbi.nlm.nih.gov/pubmed/30674940
http://dx.doi.org/10.1038/s41598-018-36680-x

Ejemplares similares